MIG Capital AG — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
BioNTech is a biotechnology company developing immunotherapies that use the body's immune system, combining multiple therapeutic modalities and biological targets to treat cancer, infectious diseases, and other serious conditions.
BiotechHealthtechMainz
Ozlem Tureci(Executive Officer)Ugur Sahin(Executive Officer)inSierk Poetting(Executive Officer)inSean Marett(Executive Officer)inRyan Richardson(Executive Officer)in
BoardChristoph Huber(Director)in
Board seatMichael Motschmann· per SEC Form D
Co-investorsManta Ray VenturesOnsight VenturesPfizer Venture Investments
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.